X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Patient Preference and Adherence

期刊標題檢索 PATIENT PREFER 最新評論: So, did you end up sending it out in the end? I've encountered the sam... (2024-02-23)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Patient Preference and Adherence]您好,您是該頁面的第 22203 位訪客。

期刊簡介
期刊名稱Patient Preference and Adherence Patient Preference and Adherence
LetPub Score
5.1
50 ratings
Rate

Reputation
5.9

Influence
3.9

Speed
7.1

期刊簡稱PATIENT PREFER ADHER
ISSN1177-889X
h-index37
CiteScore
CiteScoreSJRSNIPCiteScore Rank
3.600.6470.914
Subject fieldQuartilesRankPercentile
Category: Social Sciences
Subcategory: Social Sciences (miscellaneous)
Q1115 / 604
Category: Social Sciences
Subcategory: Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Q19 / 43
Category: Social Sciences
Subcategory: Medicine (miscellaneous)
Q2154 / 398
Category: Social Sciences
Subcategory: Health Policy
Q2126 / 310

自引率 (2023-2024)5.00%自引率趨勢
掲載範囲
Patient Preference and Adherence is an international, peer reviewed, open access journal that focuses on the growing importance of patient preference and adherence throughout the therapeutic continuum. The journal is characterized by the rapid reporting of reviews, original research, modeling and clinical studies across all therapeutic areas. Patient satisfaction, acceptability, quality of life, compliance, persistence and their role in developing new therapeutic modalities and compounds to optimize clinical outcomes for existing disease states are major areas of interest for the journal.

As of 1st April 2019, Patient Preference and Adherence will no longer consider meta-analyses for publication.
官方網站https://www.dovepress.com/patient-preference-and-adherence-journal
在線稿件提交https://www.dovepress.com/submit_step_1.php
開放訪問Yes
出版商Dove Medical Press Ltd.
主題領域MEDICINE, GENERAL & INTERNAL
出版國/地區ENGLAND
發行頻率
創刊年2007
每年文章數289每年文章數趨勢
黃金OA百分比98.54%
OA Related Info
APC: Yes( USD3300; )
APC waiver:Check Notes
Other charges: No
Keywords: patient satisfaction、quality of life、clinical outcomes
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, GENERAL & INTERNALSCIEQ2101/325
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1177-889X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Slow, 6-12 Week(s)
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【Patient Preference and Adherence】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE644443
    BIOMATERIALS595458
    Frontiers in Pharmacology499423
    BIOMEDICINE & PHARMACOTHERAPY498555
    JOURNAL OF ETHNOPHARMACOLOGY488988
    Journal of Materials Chemistry B476132
    Frontiers in Immunology460680
    COLLOIDS AND SURFACES B-BIOINTERFACES419430
    COMPUTERS IN BIOLOGY AND MEDICINE418712
    Frontiers in Oncology415226
  •  

    Patient Preference and Adherence Patient Preference and Adherence
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Patient Preference and Adherence] 的評論撰寫評論
作者: 北马横波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-23 12:36:04 評論於
So, did you end up sending it out in the end? I've encountered the same situation before
(0) 讚! | 北马横波

作者: 魔都凝心


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-26 13:14:02 評論於
Review speed: 1.0 | Submission hit rate: 50.0
Experience sharing: It has been one week since submission, and the current status is still INITIAL ASSESSMENT IN PROGRESS. I am wondering if my submission was successful
(0) 讚! | 魔都凝心

作者: 猫巷少女晴照


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-18 19:29:24 評論於
fuze
(0) 讚! | 猫巷少女晴照

作者: 韶华大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-09-27 15:27:03 評論於
Hello, my situation is the same. How are you doing behind you?
(0) 讚! | 韶华大叔

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 20:06:12 評論於
With the increasing specialization of disciplines, it is becoming increasingly difficult for journals to find appropriate peer review experts. Therefore, requesting authors to recommend reviewers is a mutually beneficial practice: journals can find suitable reviewers and save time in searching for appropriate reviewers, while authors can provide support through their own networks and recommend scholars who can best understand the submitted articles
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 10:35:01 評論於
Most journals require submissions in Word format, but there are also some that require submissions in PDF format
(0) 讚! | 维尔娜菲茨杰拉德

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 19:44:48 評論於
Should I upload a Word document or a PDF when submitting an article?
(0) 讚! | 平原文波

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 14:17:53 評論於
What is a recommended reviewer/expert/peer?
(0) 讚! | Darlene Pepys

作者: 宫古议谣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-30 17:01:30 評論於
Almost a month
(0) 讚! | 宫古议谣

作者: 削月沛绿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-01-05 17:23:37 評論於
How long has the external audit been going on?
(0) 讚! | 削月沛绿

作者: 一只妍晨呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-09-12 12:28:04 評論於
Why was my article submitted on August 16th? The status has been 1E - AWAITING EVALUATION. Does anyone know what's going on? How can I contact the editor? I couldn't find an email on the website either
(0) 讚! | 一只妍晨呀

作者: 泄矢梦晨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-09-11 14:59:43 評論於
Review Speed: 3.0 Sharing Experience: Submitted in late June, the first reviewer was quickly identified. From early July to mid-September, the search for a second reviewer has been ongoing. Finally, because a second reviewer could not be found, the responsible editor directly rejected the manuscript... It is claimed to not delay me. The rejection letter included feedback from the first reviewer, which was still quite positive. In conclusion, it is truly a quirky journal. It is recommended to be cautious when submitting
(0) 讚! | 泄矢梦晨

作者: 宫古议谣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-09-03 17:31:56 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0 Experience sharing: The processing speed is very fast. I submitted my manuscript in mid-May, and received the reviewer's comments at the end of June. There were a total of three reviewers, and their comments were very constructive. The first two reviewers were friendly, while the last one was more sharp but still hit the key points. The manuscript was accepted within a week after revisions. The editor was also very responsible. The rejection rate in the past year has been around 64%
(0) 讚! | 宫古议谣

作者: 北陆璎玑


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-06-27 22:40:24 評論於
Review Speed: 3.0 | Submission Acceptance Rate: 50.0 Experience Sharing: The editors are very responsible, with opinions from two reviewers, one suggesting major revisions and one suggesting minor revisions. If you carefully make the revisions as requested, your submission can be accepted
(0) 讚! | 北陆璎玑

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Patient Preference and Adherence] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*